Literature DB >> 25266153

Identification of Ebola virus microRNAs and their putative pathological function.

HongWei Liang1, Zhen Zhou, SuYang Zhang, Ke Zen, Xi Chen, ChenYu Zhang.   

Abstract

Ebola virus (EBOV), a member of the filovirus family, is an enveloped negative-sense RNA virus that causes lethal infections in humans and primates. Recently, more than 1000 people have been killed by the Ebola virus disease in Africa, yet no specific treatment or diagnostic tests for EBOV are available. In this study, we identified two putative viral microRNA precursors (pre-miRNAs) and three putative mature microRNAs (miRNAs) derived from the EBOV genome. The production of the EBOV miRNAs was further validated in HEK293T cells transfected with a pcDNA6.2-GW/EmGFP-EBOV-pre-miRNA plasmid, indicating that EBOV miRNAs can be produced through the cellular miRNA processing machinery. We also predicted the potential target genes of these EBOV miRNAs and their possible biological functions. Overall, this study reports for the first time that EBOV may produce miRNAs, which could serve as non-invasive biomarkers for the diagnosis and prognosis of EBOV infection and as therapeutic targets for Ebola viral infection treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25266153     DOI: 10.1007/s11427-014-4759-2

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  22 in total

1.  Ebola Virus Produces Discrete Small Noncoding RNAs Independently of the Host MicroRNA Pathway Which Lack RNA Interference Activity in Bat and Human Cells.

Authors:  Abhishek N Prasad; Adam J Ronk; Steven G Widen; Thomas G Wood; Christopher F Basler; Alexander Bukreyev
Journal:  J Virol       Date:  2020-02-28       Impact factor: 5.103

2.  Ebola virus encodes a miR-155 analog to regulate importin-α5 expression.

Authors:  Yuanwu Liu; Jing Sun; Hongwen Zhang; Mingming Wang; George Fu Gao; Xiangdong Li
Journal:  Cell Mol Life Sci       Date:  2016-04-19       Impact factor: 9.261

Review 3.  Ebola: translational science considerations.

Authors:  Francesco Chiappelli; Andre Bakhordarian; April D Thames; Angela M Du; Allison L Jan; Melissa Nahcivan; Mia T Nguyen; Nateli Sama; Ercolano Manfrini; Francesco Piva; Rafael Malagoli Rocha; Carl A Maida
Journal:  J Transl Med       Date:  2015-01-16       Impact factor: 5.531

4.  ALV-miRNA-p19-01 Promotes Viral Replication via Targeting Dual Specificity Phosphatase 6.

Authors:  Yiming Yan; Sheng Chen; Liqin Liao; Shuang Gao; Yanling Pang; Xinheng Zhang; Huanmin Zhang; Qingmei Xie
Journal:  Viruses       Date:  2022-04-13       Impact factor: 5.818

Review 5.  Diagnostic and Prognostic Value of MicroRNA in Viral Diseases.

Authors:  Eeva Auvinen
Journal:  Mol Diagn Ther       Date:  2017-02       Impact factor: 4.074

Review 6.  Ebolavirus comparative genomics.

Authors:  Se-Ran Jun; Michael R Leuze; Intawat Nookaew; Edward C Uberbacher; Miriam Land; Qian Zhang; Visanu Wanchai; Juanjuan Chai; Morten Nielsen; Thomas Trolle; Ole Lund; Gregory S Buzard; Thomas D Pedersen; Trudy M Wassenaar; David W Ussery
Journal:  FEMS Microbiol Rev       Date:  2015-07-14       Impact factor: 16.408

7.  Systematic Genome-wide Screening and Prediction of microRNAs in EBOV During the 2014 Ebolavirus Outbreak.

Authors:  Yue Teng; Yuzhuo Wang; Xianglilan Zhang; Wenli Liu; Hang Fan; Hongwu Yao; Baihan Lin; Ping Zhu; Wenjun Yuan; Yigang Tong; Wuchun Cao
Journal:  Sci Rep       Date:  2015-05-26       Impact factor: 4.379

8.  Induction of the pro-inflammatory NF-kB-sensitive miRNA-146a by human neurotrophic viruses.

Authors:  James M Hill; Christian Clement; Yuhai Zhao; Walter J Lukiw
Journal:  Front Microbiol       Date:  2015-02-03       Impact factor: 5.640

Review 9.  RNA Virus-Encoded miRNAs: Current Insights and Future Challenges.

Authors:  Asuka Nanbo; Wakako Furuyama; Zhen Lin
Journal:  Front Microbiol       Date:  2021-06-24       Impact factor: 5.640

Review 10.  Ebolavirus Evolution: Past and Present.

Authors:  Marc-Antoine de La Vega; Derek Stein; Gary P Kobinger
Journal:  PLoS Pathog       Date:  2015-11-12       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.